All seven patients with Wegener's granulomatosis gave a cytoplasmic pattern of staining but, as expected, the three patients with systemic necrotising vasculitis also gave a perinuclear pattern. This pattern was indistinguishable from the perinuclear pattern in the PSC and UC groups. All other controls were negative (Fig 2) . Of the 41 ANCA positive PSC patients, 34 were negative when tested on formal acetone fixed neutrophils, six gave a granular cytoplasmic pattern, and one a homogenous cytoplasmic pattern. In the UC group, 33 of the 38 patients positive on alcohol fixed neutrophils gave no staining at all on formal acetone fixed neutrophils, whereas the remaining five demonstrated a granular cytoplasmic pattern. Fifteen ANCA positive UC patients were tested for ANA on rat liver substrate and HEP 2 cells at a serum dilution of 1:5. Of these, only two had ANA present at a 1:5 serum dilution. One of these had only a weak ANA at a dilution of 1:40 but had ANCA present at a dilution of at least 1:50. In the case of the PSC ANCA positive group, six of the 18 tested had ANA at a titre of 1:40 or above.
In the case of the PSC group (Table IV) immunosuppressive drugs, this was not statistically significant compared with the ANCA negative UC patients. However, ANCA positive UC patients had a significantly longer median duration of disease than ANCA negative patients (Table V ). The precise importance of this finding is unclear as this has not been shown by other groups,2 4 6 7 and indeed in two of our 38 ANCA positive UC patients, ANCA was detected even after they had had a colectomy. This has been observed by others2 and suggests that the diseased organ is not essential for ANCA generation once a clone of B cells has been 'programmed' for antibody production.
The only significant association in the ANCA positive PSC group (Table IV) 16 However, these patients were also more likely to have biliary tract calculi and as this is associated with recurrent cholangitis and a poorer outcome it could be argued that in this study ANCA was merely a marker of the presence of calculi rather than of prognosis.
At present, the gold standard for diagnosis of PSC remains an endoscopic retrograde cholangiopancreatogram.5 Liver histology, although characteristic, may be focal, and liver function tests are also unreliable. We have previously discussed the potential diagnostic use of ANCA as a non-invasive test to screen for PSC in childhood. '7 In the present study, patients with PSC+UC had higher ANCA titres than those with UC only (ANCA The age of onset of UC typically precedes that of PSC by 10-20 years. If ANCA is UC associated and, as in this study, prevalence is associated with longer median disease duration, then it could be argued that the higher prevalence in UC+PSC may simply by a UC associated phenomenon with PSC developing as a complication of UC. In this context it is interesting to note that ANCA positive PSC patients in the present study tended to be older than ANCA negative PSC patients (Table IV) and both titre and IgG subclass of ANCA differ between UC only and PSC+UC, suggesting that an alteration in underlying immune mechanisms may play a role in the development of PSC. Similarly, it is interesting to note that in the present study only 29% of PSC only patients were ANCA positive at 1:5, dropping to 14% at 1:50. This might also suggest that ANCA in PSC+IUC is UC associated. Unfortunately the duration of UC in the PSC+UC group could not be determined and compared with the UC only group. Therefore, whether the higher ANCA prevalence in the former group was due to longer duration of UC is not clear. However, patients with PSC+Crohn's disease had a similar ANCA prevalence to those with PSC+UC (67% and 70% at 1:5 respectively) as well as a similar ANCA IgG subclass distribution (unpublished observation). As the prevalence of ANCA in Crohn's disease is very low (0/32 in a previous study from our group4) this finding would argue against ANCA being UC associated in PSC+UC and suggests that it is due to the PSC itself. In support of this, Duerr et al,' using a combination of fixed neutrophil ELISA and immunofluorescence, detected perinuclear ANCA in 8 of 14 (58%) PSC only sera. Furthermore, the detection of ANCA in the serum of patients with autoimmune hepatitis and primary biliary cirrhosis in some studies3 22 However, a predominance of the IgGl and IgG3 isotypes for both UC only and PSC+UC ANCA is in keeping with evidence to date which suggests that the antigen is likely to be proteinaceous in nature4 as this is the predominant response produced against protein antigens. 14 Furthermore, although some differences in IgG subclass distribution were noted between UC only and UC+PSC ANCA, suggesting possible differences in immune regulation, this does not necessarily imply that the antigen(s) for PSC ANCA differ(s) from that in UC ANCA. In Wegener's granulomatosis the same antigen (namely serine proteinase 3) is able to elicit a variable IgG subclass response and in this way influence the pathogenesis of the disease process.1825 The same could conceivably be true of PSC and UC ANCA antigen(s).
In conclusion, in the present study we have shown that ANCA is a diagnostic marker of disease in both UC and PSC. In UC, ANCA was associated with significantly longer median disease duration whereas in PSC, ANCA was significantly associated with the extent of involvement of the biliary tree. Further studies are needed to verify these findings. While the higher titre and different IgG subclass distribution of ANCA in PSC+UC compared with UC only suggests differences in underlying immune regulation, determination of ANCA titre and IgG subclass is unlikely to have a role in distinguishing between PSC+UC and UC only ANCA. Future identification of the antigen(s) against which ANCA is/are directed should allow the development of a more sensitive and specific test for the diagnosis of these conditions and also determine whether ANCA is associated with UC or PSC. 
